Infection and drug resistance

[1] estimating the public health impact of setting targets at the european level for the reduction of zoonotic salmonella in certain poultry populations

[2] bila kecemasan mendera tugas konseling mencari solusinya

[3] optimal target blood pressure level for elderly with hypertension

[4] some remarks on right node raising in romanian

[5] A novel flurophore-cyano-carboxylic-Ag microhybrid: Enhanced two photon absorption for two-photon photothermal therapy of HeLa cancer cells by targeting mitochondria.

[6] Untargeted Metabolomic Screen Reveals Changes in Human Plasma Metabolite Profiles Following Consumption of Fresh Broccoli Sprouts

[7] Cognitive dysfunction in depression - pathophysiology and novel targets.

[8] Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo.

[9] Targeting mitochondria with Au-Ag@Polydopamine nanoparticles for papillary thyroid cancer therapy.

[10] Target-recycling-amplified colorimetric detection of pollen allergen using non-cross-linking aggregation of DNA-modified gold nanoparticles.

[11] Starburst Poly(amidoamine) Dendrimer Grafted Gold Nanoparticles as a Scaffold for Folic Acid-Targeted Plasmid DNA Delivery In Vitro

[12] Synthetic lethal interaction between oxidative stress response and DNA damage repair in the budding yeast and its application to targeted anticancer therapy.

[13] Parallel identification of novel antimicrobial peptide sequences from multiple anuran species by targeted DNA sequencing.

[14] Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.

[15] SRAPs and EST-SSRs provide useful molecular diversity for targeting drought and salinity tolerance in Indian mustard.

[16] CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.

[17] Identification of Per- and Polyfluoroalkyl Substances in the Cape Fear River by High Resolution Mass Spectrometry and Nontargeted Screening.

[18] Targeting the pattern-triggered immunity pathway to enhance resistance to Fusarium graminearum.

[19] Phytophthora infestans effector SFI3 targets potato UBK to suppress early immune transcriptional responses.

[20] Identification of HSP90 as a direct target of artemisinin for its anti-inflammatory activity via quantitative chemical proteomics.

[21] Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against HO- and Aβ-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells.

[22] Cognitive dysfunction in depression - pathophysiology and novel targets.

[23] Analysis of Young Shoots of 'Anji Baicha' (Camellia sinensis) at Three Developmental Stages Using Nontargeted LC-MS-Based Metabolomics.

[24] Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against HO- and Aβ-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells.

[25] Synthesis and biological evaluation of flavone-8-acrylamide derivatives as potential multi-target-directed anti Alzheimer agents and investigation of binding mechanism with acetylcholinesterase.

[26] Human mitochondrial carnitine acylcarnitine carrier: Molecular target of dietary bioactive polyphenols from sweet cherry (Prunus avium L.).

[27] Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study.

[28] New alkoxy flavone derivatives targeting caspases: Synthesis and antitumor activity evaluation

[29] Toward Rational Design of Novel Anti-Cancer Drugs Based on Targeting, Solubility, and Bioavailability Exemplified by 1,3,4-Thiadiazole Derivatives Synthesized Under Solvent-Free Conditions.

[30] Linker Optimization and Therapeutic Evaluation of Phosphatidylserine-Targeting Zinc Dipicolylamine-based Drug Conjugates.

[31] Targeted gold nanoparticles enable molecular CT imaging of head and neck cancer: An in vivo study.

[32] Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood–brain barrier penetration

[33] The potential medicinal value of plants from Asteraceae family with antioxidant defense enzymes as biological targets.

[34] Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque.

[35] Development of species specific putative miRNA and its target prediction tool in wheat (Triticum aestivum L.).

[36] How to Develop a Drug Target Ontology: KNowledge Acquisition and Representation Methodology (KNARM).

[37] Targeting multiple myeloma with natural polyphenols.

[38] Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects.

[39] RALBP1 regulates oral cancer cells via Akt and is a novel target of miR-148a-3p and miR-148b-3p.

[40] Estrogen receptor-mediated targeting of the extracellular matrix network in cancer.

[41] Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR.

[42] Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages.

[43] Targeting malaria and leishmaniasis: Synthesis and pharmacological evaluation of novel pyrazole-1,3,4-oxadiazole hybrids. Part II

[44] Targeting hepatocellular carcinoma: Synthesis of new pyrazole-based derivatives, biological evaluation, DNA binding, and molecular modeling studies

[45] Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.

[46] Quantitative changes in proteins responsible for flavonoid and anthocyanin biosynthesis in strawberry fruit at different ripening stages: A targeted quantitative proteomic investigation employing multiple reaction monitoring.

[47] Identification of Potential Drug-targets by Combining Evolutionary Information Extracted from Frequency Profiles and Molecular Topological Structures.

[48] First-In-Class Inhibitors Targeting the Interaction between Bacterial RNA Polymerase and Sigma Initiation Factor Affect the Viability and Toxin Release of Streptococcus pneumoniae

[49] Complementary Untargeted and Targeted Metabolomics for Differentiation of Extra Virgin Olive Oils of Different Origin of Purchase Based on Volatile and Phenolic Composition and Sensory Quality

[50] Unique Roles of Gold Nanoparticles in Drug Delivery, Targeting and Imaging Applications

[51] Targeting CD20 in chronic lymphocytic leukemia

[52] Targeting modifiable risk factors in age-related macular degeneration in optometric practice in Sweden

[53] Indole-core-based novel antibacterial agent targeting FtsZ

[54] Staphyloxanthin: a potential target for antivirulence therapy

[55] Evaluation of the accuracy of molecular assays targeting the mutation A2059G for detecting high-level azithromycin resistance in Neisseria gonorrhoeae: a systematic review and meta-analysis

[56] Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis

[57] High-dose amikacin for achieving serum target levels in critically ill elderly patients

[58] Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics

[59] Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives

[60] Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

[61] The androgen receptor as an emerging target in hepatocellular carcinoma

[62] c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma

[63] Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma

[64] Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma

[65] Potential of PCSK9 as a new target for the management of LDL cholesterol

[66] SERCA2a: its role in the development of heart failure and as a potential therapeutic target

[67] New targets and developments in lipoproteins control

[68] High-density lipoproteins: a novel therapeutic target for cardiovascular disease

[69] Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study

[70] Targeting CD20 in chronic lymphocytic leukemia

[71] Targeting modifiable risk factors in age-related macular degeneration in optometric practice in Sweden

[72] Indole-core-based novel antibacterial agent targeting FtsZ

[73] Staphyloxanthin: a potential target for antivirulence therapy

[74] Targeting CD20 in chronic lymphocytic leukemia

[75] Targeting modifiable risk factors in age-related macular degeneration in optometric practice in Sweden

[76] Indole-core-based novel antibacterial agent targeting FtsZ

[77] Staphyloxanthin: a potential target for antivirulence therapy

[78] Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach

[79] GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson’s Disease: A Mini Review

[80] Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90 of HIV-Infected Individuals

[81] Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era

[82] Evaluation of the accuracy of molecular assays targeting the mutation A2059G for detecting high-level azithromycin resistance in Neisseria gonorrhoeae: a systematic review and meta-analysis

[83] Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis

[84] High-dose amikacin for achieving serum target levels in critically ill elderly patients

[85] Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy

[86] Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics

[87] Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study

[88] Targeting HIF-1α to Prevent Renal Ischemia-Reperfusion Injury: Does It Work?

[89] Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives

[90] Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

[91] The androgen receptor as an emerging target in hepatocellular carcinoma

[92] c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma

[93] Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma

[94] Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma

[95] Sheep enteric cestodes and their influence on clinical indicators used in targeted selective treatments against gastrointestinal nematodes

[96] Potential of PCSK9 as a new target for the management of LDL cholesterol

[97] SERCA2a: its role in the development of heart failure and as a potential therapeutic target

[98] New targets and developments in lipoproteins control

[99] High-density lipoproteins: a novel therapeutic target for cardiovascular disease

[100] Correction to: An Efficient Synthesis of Deoxyrhapontigenin- 3-O-β?D-glucuronide, a brain-targeted derivative of dietary resveratrol, and its precursor 4′-O-me-resveratrol (ACS Omega (2019) 4:5 (8222-8230) DOI: 10.1021/acsomega.9b00722)

[101] Correction: Targeted reinforcement of macrophage reprogramming toward M2 polarization by IL-4-loaded hyaluronic acid particles (ACS Omega (2018) 1:12 (18444-18455) DOI: 10.1021/acsomega.8b03182)